1. Home
  2. IMRN vs EDUC Comparison

IMRN vs EDUC Comparison

Compare IMRN & EDUC Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • IMRN
  • EDUC
  • Stock Information
  • Founded
  • IMRN 1994
  • EDUC 1965
  • Country
  • IMRN Australia
  • EDUC United States
  • Employees
  • IMRN N/A
  • EDUC N/A
  • Industry
  • IMRN Biotechnology: Pharmaceutical Preparations
  • EDUC Consumer Specialties
  • Sector
  • IMRN Health Care
  • EDUC Consumer Discretionary
  • Exchange
  • IMRN Nasdaq
  • EDUC Nasdaq
  • Market Cap
  • IMRN 9.2M
  • EDUC 11.4M
  • IPO Year
  • IMRN N/A
  • EDUC N/A
  • Fundamental
  • Price
  • IMRN N/A
  • EDUC $1.30
  • Analyst Decision
  • IMRN Strong Buy
  • EDUC
  • Analyst Count
  • IMRN 1
  • EDUC 0
  • Target Price
  • IMRN $5.00
  • EDUC N/A
  • AVG Volume (30 Days)
  • IMRN 24.6K
  • EDUC 4.4K
  • Earning Date
  • IMRN 07-15-2025
  • EDUC 07-10-2025
  • Dividend Yield
  • IMRN N/A
  • EDUC N/A
  • EPS Growth
  • IMRN N/A
  • EDUC N/A
  • EPS
  • IMRN N/A
  • EDUC N/A
  • Revenue
  • IMRN $4,048,286.00
  • EDUC $34,191,000.00
  • Revenue This Year
  • IMRN N/A
  • EDUC N/A
  • Revenue Next Year
  • IMRN N/A
  • EDUC N/A
  • P/E Ratio
  • IMRN N/A
  • EDUC N/A
  • Revenue Growth
  • IMRN 82.90
  • EDUC N/A
  • 52 Week Low
  • IMRN $1.50
  • EDUC $0.92
  • 52 Week High
  • IMRN $2.87
  • EDUC $2.49
  • Technical
  • Relative Strength Index (RSI)
  • IMRN 49.46
  • EDUC 48.93
  • Support Level
  • IMRN $1.56
  • EDUC $1.27
  • Resistance Level
  • IMRN $1.96
  • EDUC $1.37
  • Average True Range (ATR)
  • IMRN 0.11
  • EDUC 0.06
  • MACD
  • IMRN -0.01
  • EDUC -0.00
  • Stochastic Oscillator
  • IMRN 53.75
  • EDUC 31.58

About IMRN Immuron Limited

Immuron Ltd is a commercial and clinical-stage biopharmaceutical company focused on the development and commercialization of a novel class of immunomodulator polyclonal antibodies to treat liver diseases, infectious diseases and other immune-mediated diseases, such as colitis. The company's product, IMM-124E, is a proprietary immunomodulatory agent targeted at GI immune-mediated diseases including fatty liver diseases. The company functions in two segments namely, Research and Development and Hyperimmune products.

About EDUC Educational Development Corporation

Educational Development Corp is the United States trade publisher of the line of educational children's books produced in the United Kingdom. Its business activity functions with two reportable segments: PaperPie and Publishing. The Publishing Division segment markets its products to retail accounts, which include books, school supplies, toy and gift stores and museums, through commissioned sales representatives, trade and specialty wholesalers and an internal telesales group.

Share on Social Networks: